Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation: study protocol of the No.2-trial, a multicenter open-label randomized controlled trial and cost-effectiveness analysis

PURPOSE: The evidence regarding the (cost-)effectiveness of sacral neuromodulation (SNM) in patients with therapy-resistant idiopathic slow-transit constipation is of suboptimal quality. The Dutch Ministry of Health, Welfare and Sports has granted conditional reimbursement for SNM treatment. The obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Heemskerk, S. C. M., Rotteveel, A. H., Benninga, M. A., Baeten, C. I. M., Masclee, A. A. M., Melenhorst, J., van Kuijk, S. M. J., Dirksen, C. D., Breukink, S. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Clinical Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859034/
https://www.ncbi.nlm.nih.gov/pubmed/29470731
http://dx.doi.org/10.1007/s00384-018-2978-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859034/
https://www.ncbi.nlm.nih.gov/pubmed/29470731
http://dx.doi.org/10.1007/s00384-018-2978-x

Ejemplares similares